CONNECT WITH US
HealthTech

HealthTech

Verily Health Awarded CDC Contract for National Wastewater Surveillance System: Scaling Genomic and Metagenomic Public Health Analytics

HIT Consultant logo

Published on

Add as a preferred source on Google
Verily Health Awarded CDC Contract for National Wastewater Surveillance System: Scaling Genomic and Metagenomic Public Health Analytics

Healthcare data intelligence leader Verily Health Inc. h as been awarded a multi-year contract renewal by the Centers for Disease Control and Prevention (CDC) to continue operating and expanding the National Wastewater Surveillance System (NWSS).

Builds on a four-year operational foundation: the contract extension expands the public health surveillance partnership Verily has maintained with the CDC since 2023.

Delivered through Verily Sightline, the company’s specialized public health platform that unifies wastewater epidemiology, high-throughput molecular laboratory testing, bioinformatic data analytics, and software infrastructure to monitor population-level infectious disease transmission trends.

Introduces advanced genomic capabilities: the expanded CDC program will support continuous pathogen detection, targeted viral and bacterial genomic sequencing, and the incorporation of potential metagenomic surveillance capabilities to detect novel and emerging pathogens before they appear in clinical settings.

Under the renewed CDC mandate, Verily combines physical laboratory pipelines with population-level health informatics to track infectious disease dynamics:

End-to-End Operational Pipeline: Verily Sightline integrates sample intake from municipal wastewater treatment facilities, high-throughput biospecimen processing, quantitative PCR assays, and automated cloud data pipelines that feed actionable epidemiological intelligence directly into CDC reporting dashboards.

Pathogen-Specific Assays: Continues routine monitoring for established respiratory and gastrointestinal pathogens, including SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus (RSV), alongside flexible surge testing for emerging zoonotic threats such as avian influenza (H5N1).

Genomic Sequencing & Variant Tracking: Performs high-density genomic sequencing to track lineage mutations, detect novel viral variants, and monitor antimicrobial resistance (AMR) markers before they appear in clinical hospital isolates.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.